Shabbir Iqra, Liu Keying, Riaz Bakhtawar, Rahim Muhammad Farhan, Zhong Saiyi, Aweya Jude Juventus, Cheong Kit-Leong
College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.
Department of Clinical Studies, Arid Agriculture University, Rawalpindi 43600, Pakistan.
Nutrients. 2025 Apr 4;17(7):1268. doi: 10.3390/nu17071268.
The ketogenic diet (KD) is a dietary intervention comprising a high-fat, low-carbohydrate, and moderate-protein intake designed to induce a metabolic state known as ketosis, whereby ketone bodies are produced as an alternative source of energy. Initially established as a treatment for intractable epilepsy, the KD has subsequently gained significant attention for its potential to manage neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's disease. Ketone bodies, such as beta-hydroxybutyrate (BHB), have been demonstrated to possess neuroprotective properties. The increasing prevalence of neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's disease, poses a significant public health challenge worldwide. With neurological disorders being the second-leading cause of death globally, the need for effective therapeutic interventions has never been more urgent. Recent evidence suggests that dietary interventions, particularly the ketogenic diet, offer promising potential in mitigating the progression of these diseases by influencing metabolic processes and providing neuroprotective benefits. The ketogenic diet, characterized by high-fat and low-carbohydrate intake, induces ketosis, leading to the production of ketone bodies like beta-hydroxybutyrate, which enhance mitochondrial efficiency, reduce oxidative stress, and modulate inflammatory pathways-mechanisms critical in neurodegenerative pathophysiology. This review explores the role of the ketogenic diet in managing neurological conditions, examining its mechanisms of action, historical context, and therapeutic efficacy. The paper also discusses emerging evidence linking the ketogenic diet to improved cognitive function, reduced motor symptoms, and enhanced mitochondrial activity in patients with neurodegenerative disorders. Additionally, the review highlights the need for further research to refine the therapeutic applications of the ketogenic diet, investigate its impact on various neurodegenerative diseases, and better understand its potential long-term effects. This study underscores the importance of nutrition as a vital aspect of the treatment strategy for neurological diseases, advocating for continued exploration of dietary interventions to improve brain health and function.
生酮饮食(KD)是一种饮食干预方式,其特点是高脂肪、低碳水化合物和适量蛋白质摄入,旨在诱导一种称为酮症的代谢状态,在此状态下酮体作为替代能量来源产生。生酮饮食最初被确立为治疗难治性癫痫的方法,随后因其在管理包括阿尔茨海默病、帕金森病和亨廷顿病在内的神经退行性疾病方面的潜力而受到广泛关注。酮体,如β-羟基丁酸(BHB),已被证明具有神经保护特性。阿尔茨海默病、帕金森病和亨廷顿病等神经退行性疾病的患病率不断上升,在全球范围内构成了重大的公共卫生挑战。由于神经系统疾病是全球第二大死因,因此对有效治疗干预措施的需求从未如此迫切。最近的证据表明,饮食干预,特别是生酮饮食,通过影响代谢过程和提供神经保护益处,在减轻这些疾病的进展方面具有广阔的潜力。以高脂肪和低碳水化合物摄入为特征的生酮饮食会诱导酮症,导致产生如β-羟基丁酸等酮体,这些酮体可提高线粒体效率、减少氧化应激并调节炎症途径,而这些机制在神经退行性病理生理学中至关重要。本综述探讨了生酮饮食在管理神经系统疾病中的作用,研究了其作用机制、历史背景和治疗效果。本文还讨论了将生酮饮食与神经退行性疾病患者认知功能改善、运动症状减轻和线粒体活性增强联系起来的新证据。此外,该综述强调需要进一步研究以完善生酮饮食的治疗应用,研究其对各种神经退行性疾病的影响,并更好地了解其潜在的长期影响。这项研究强调了营养作为神经系统疾病治疗策略重要方面的重要性,主张继续探索饮食干预措施以改善大脑健康和功能。